Get startedLog in
    Picture of Esperion Therapeutics logo

    ESPR — Esperion Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapValue Trap
    All News

    Archimed to take Esperion Therapeutics private for up to $1.1 billion

    Picture of Esperion Therapeutics logoEsperion Therapeutics
    01/05/2026 12:07
    Corrects to say Esperion is a drugmaker, not drug developer, in paragraph 1

May 1 (Reuters) - Investment firm Archimed said on Friday it will take drugmaker Esperion Therapeutics ESPR.O private for up to $1.1 billion.

 (Reporting by Sriparna Roy in Bengaluru)

 ((Sriparna.Roy@thomsonreuters.com;))

    Recent news on Esperion Therapeutics

    See all news